Catalog No.
AHJ38601
Biological activity
Measured by its binding ability in a functional ELISA. When recombinant human CD352/SLAMF6 (Cat #: AHJ38601) is coated at 1 μg/mL (100 μL/well), the concentration of biotinylated recombinant human CD352/SLAMF6 that produces 50% optimal binding response is 0.6-3 μg/mL.
Expression system
Mammalian Cells
Species
Homo sapiens (Human)
Protein length
Gln22-Met226
Nature
Recombinant
Endotoxin level
<0.1 EU/μg of the protein by the LAL method.
Purity
>90% as determined by SDS-PAGE.
Accession
Q96DU3
Applications
Bioactivity, ELISA, Immunogen, SDS-PAGE, WB
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 5% Trehalose, 5% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for one week. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
CD352, NTB-A, NK-T-B-antigen, KALI, SLAMF6, Activating NK receptor, SLAM family member 6
Functional characterization of maternally accumulated hydrolases in the mature oocytes of the vector Rhodnius prolixus reveals a new protein phosphatase essential for the activation of the yolk mobilization and embryo development., PMID:36923285
Immune Functions of Signaling Lymphocytic Activation Molecule Family Molecules in Multiple Myeloma., PMID:33451089
Brief report: Decreased expression of CD244 (SLAMF4) on monocytes and platelets in patients with systemic lupus erythematosus., PMID:28593610
A combination of an anti-SLAMF6 antibody and ibrutinib efficiently abrogates expansion of chronic lymphocytic leukemia cells., PMID:27029059
Multiple myeloma: New surface antigens for the characterization of plasma cells in the era of novel agents., PMID:26287276
The cell surface receptor Slamf6 modulates innate immune responses during Citrobacter rodentium-induced colitis., PMID:25957267
NK cell cytotoxicity mediated by 2B4 and NTB-A is dependent on SAP acting downstream of receptor phosphorylation., PMID:23346089
Characterization of Ly108 in the thymus: evidence for distinct properties of a novel form of Ly108., PMID:22393150
SLAMF6-driven co-stimulation of human peripheral T cells is defective in SLE T cells., PMID:21231893
Expression of SLAM (CD150) cell-surface receptors on human B-cell subsets: from pro-B to plasma cells., PMID:20933013
Analysis of HLDA9 mAbs on plasmacytoid dendritic cells., PMID:20933012
New B-cell CD molecules., PMID:20933010
Differential expression of SLAMS and other modulatory molecules by human plasma cells during normal maturation., PMID:20923684
For research use only. Not for human or drug use.
